Lightbridge is expected to report zero revenue and a consensus EPS loss of $0.20 for Q3 2026, with the stock currently trading at $5.05 against an average analyst target of $10.10. Investors are primarily focused on the progress of fuel rod testing and the upcoming post-irradiation examination (PIE) at the Idaho National Laboratory (INL).
The company recently reached a milestone by securing access to INL's Advanced Test Reactor loop facility to test fuel under commercial conditions. While Lightbridge maintains a robust cash position of approximately $237.5 million, shareholders are closely monitoring rising research and development expenses as the company advances its multi-lobed metallic fuel design toward commercialization.